Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis

Locally Advanced Nasopharyngeal Carcinoma: Delivering Neoadjuvant Chemotherapy Prior to Concurrent Chemoradiation Therapy

Neoadjuvant Chemotherapy With TPF Regimen Followed by Concurrent Chemoradiation for Locoregionally Advanced Stage Nasopharyngeal Carcinoma

Neoadjuvant Chemotherapy Associated With Improved Survival in High-Risk Nasopharyngeal Carcinoma Patients Treated With Definitive Concurrent Chemoradiation Therapy

Neoadjuvant Chemotherapy followed by Concurrent Chemoradiation for Locoregionally Advanced Stage Nasopharyngeal Carcinoma: Preliminary Report of Two Phase II Trials

Encouraging early results for advanced stage III-IV nasopharyngeal carcinoma using neoadjuvant-concurrent chemotherapy and accelerated radiotherapy

Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma

Nimotuzumab in the Combination With Neoadjuvant Chemotherapy Followed By Concurrent Chemoradiation Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma Patients in Endemic Area: A Retrospective Study

Neoadjuvant Chemotherapy Followed by Concurrent Chemo-Radiation Therapy in Locally Advanced Nasopharyngeal Carcinoma: Single Institute Experience

Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival